At the end of 2016, MD+DI an industry report correctly predicted that value-based care was here to stay. Fast-forward two years and we're beginning to see hard evidence that the industry is not only accepting this shift but some medtech companies have even learned to embrace it.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,